Health Services Research
Latest posts by Health Services Research (see all)
- Community Discharge of Nursing Home Residents: The Role of Facility Characteristics - Jul. 27, 2015
- Comparing the Cost of Caring for Medicare Beneficiaries in Federally Funded Health Centers to… - Jul. 27, 2015
- Enhancing the Value of Statewide Hospital Discharge Data: Improving Clinical Content and… - Jul. 24, 2015
- Percutaneous Coronary Intervention in the United States: Risk Factors for Untimely Access - Jul. 14, 2015
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.